Changes in hormones, lipids and symptoms after the administration of a commercial preparation with dehydroepiandrosterone in postmenopausal women.
Carranza-Lira
S
S
Gynecologic Endocrinology Service, Hospital de Ginecología y Obstetricia Luis Castelazo Ayala. scarranzal@mexis.com
Nájera Mojica
J L
JL
Herrera
J
J
Ramos-Ponce
D
D
Olivares-Segura
A
A
Cardoso-Saldaña
G
G
Posadas-Romero
C
C
D000368:Aged; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D003687:Dehydroepiandrosterone / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006728:Hormones / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D017698:Postmenopause / Q000502:physiology*; D014280:Triglycerides / Q000097:blood
D006728:Hormones; D008055:Lipids; D014280:Triglycerides; D003687:Dehydroepiandrosterone; D002784:Cholesterol